Interferon-alpha 7 Human Recombinant, Sf9
Interferon-alpha 1 Porcine Recombinant
Interferon-Alpha 2b Human Recombinant, Yeast
Recombinant Human Interferon-alpha 2b, produced in yeast, is a single, glycosylated polypeptide chain with a molecular weight of approximately 19.3 kDa, comprising 165 amino acids. The purification process involves proprietary chromatographic techniques.
IFN-Beta 1a Human Recombinant
IFN-Beta 1b Human Recombinant
Interferon Alpha And Beta Receptor Mouse Recombinant
Interferon Alpha And Beta Receptor Subunit 2 Human Recombinant
Sf9, Baculovirus cells.
Interferon-gamma 139 a.a Human Recombinant
Interferon-gamma Canine Recombinant
IFN-Alpha 2b Human Recombinant
Recombinant Human IFN-a 2b, produced in E. coli, is a non-glycosylated polypeptide chain consisting of 166 amino acids. With a molecular weight of 19400 Daltons, it differs from IFN-alpha 2a by a single amino acid at position 23 (arginine in IFN-alpha 2b instead of lysine in IFN-alpha 2a). The IFN-alpha 2b gene originates from human leukocytes, and the protein is purified using proprietary chromatographic techniques.
Interferons (IFNs) are a group of signaling proteins produced and released by host cells in response to the presence of pathogens, such as viruses, bacteria, and parasites . They belong to the larger class of proteins known as cytokines, which are crucial for communication between cells to trigger the protective defenses of the immune system . Interferons are named for their ability to “interfere” with viral replication within host cells .
Interferons are classified into three main types based on the type of receptor through which they signal:
Interferons exhibit several key biological properties:
Interferons play several crucial roles in the immune system:
Interferons exert their effects through several mechanisms:
The expression and activity of interferons are tightly regulated:
Interferons have several applications in biomedical research and medicine:
Interferons play a role throughout the life cycle, from development to aging and disease: